Indivior Pharmaceuticals, Inc. · Drugmakers

INDV

Moderate riskNext report: In 2 days (est.)

View price ↗

The short version

A profitable company with growing sales.

Going well

Sales up 14% in the latest quarter vs a year ago
Profitable, keeps 17% of sales as profit
Buying back shares: share count down 7.9% in 3 years

Watch out for

Owes more than it owns (negative equity)
Bills due within a year exceed short-term assets

Money moves

No insider buying or selling in the last 30 days
Institutions cut 3.7% from their holdings in the quarter ending June 2026 (196 bought, 144 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$34.60+0.4% that day

Company value: $4.1B; Share price times all shares
Price vs profit (P/E): 12.4x; You pay about $12 for each $1 of yearly profit
Price vs sales: 3.1x; Company value is 3.1 times a year of sales
Cash vs value: 5%; Cash as a share of company value
Debt vs value: 8%; Debt as a share of company value

From INDV's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 10 quarters, from SEC filings

Sales, Jun '26

$343.0M+14% vs a year earlier

Mar '24Tap a barJun '26

Last 12 months: $1.3B, up 13% from the 12 months before.

What the price assumes

Your guesses, our math

Move the sliders to your own view of INDV. Starting points are the company's recent numbers.

Sales growth+13% a yearRecently: +13% a yearProfit margin27%Last 12 months: 26.7%P/E at the end12xToday: 12.4x. Many steady companies trade at 12x to 25xShare count change-3% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$2.5B

Profit in 5 years$663M

Price these guesses point to$78.46+127% vs $34.60 todayAbout +18% a year, before dividends

What today's price needs: with a 27% margin and a 12x P/E, sales could shrink about 4.1% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/5Mixed

MissDebt under half of equityNot relying on borrowed money.Owes more than it owns
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.16.9%
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$93.0M
PassShare count not growingNot diluting owners. Falling means buybacks.-7.9% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.80.2%

Revenue: $1.2B; +4.3% vs prior year
Total debt: $319.0M
Current ratio: 0.71x; short-term assets / bills due
Free cash flow: -$93.0M; -7.5% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, profitable every year. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 3

Revenue: $343.0M; +13.6% YoY
EPS: $0.98; vs $0.14
Op. margin: 46.6%; +22.8 pts
Gross margin: 85.7%; +2.9 pts
Free cash flow: $222.0M
Share count: -1.6%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.8
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady-3.7%

Institutions cut 3.7% from their holdings. 196 bought, 144 sold.

Shares held by institutions122.9M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-2.7%

Cash runwayAt last year's cash burn

99 months

Debt to equityLatest balance sheet: debt compared with what owners have

Owes more than it owns

Shares outstandingLatest reported

118M

Why moderate risk

Owes more than it owns (negative equity)
Bills due within a year exceed short-term assets

Earnings reports

Last 6

Next reportIn 2 days (est.)Estimated from the same quarter last year

Results filedAug 3
Results filedApr 30
Results filedFeb 26
Results filedOct 30, 2025
Results filedJul 31, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

New 5%+ holder (passive)Sep 30 · View filing ↗Big holder Offering prospectusSep 11 · View filing ↗Offering 5%+ holder update (active)Aug 13 · View filing ↗Activist

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Shareholder vote resultsOct 15 · Form 8-K ↗Other company newsOct 6 · Form 8-K ↗425Oct 6 · Form 425 ↗New 5%+ holder (passive)Sep 30 · Form SCHEDULE 13G ↗Investor disclosureSep 17 · Form 8-K ↗425Sep 17 · Form 425 ↗Current reportSep 15 · Form 8-K ↗Offering prospectusSep 11 · Form 424B3 ↗EFFECTSep 11 · Form EFFECT ↗S-4/ASep 9 · Form S-4/A ↗S-4Aug 28 · Form S-4 ↗

BoughtWoodrow D AndersonChief Accounting Officer

1,500 shares at $35.69 · $54K

+6% of holdings
Now owns 27,638 shares
Filed same day

Aug 27Form 4 ↗

5%+ holder update (active)Aug 13 · Form SCHEDULE 13D/A ↗

BoughtWoodrow D AndersonChief Accounting Officer

1,500 shares at $36.28 · $54K

+6% of holdings
Now owns 26,138 shares
Filed same day

Aug 5Form 4 ↗

425Aug 4 · Form 425 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page